Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery: a Single-center Randomized Controlled Study(KISS Study)

NCT07062952 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT07062952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07062952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery: a Single-center Randomized Controlled Study(KISS Study)
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2025
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, egfr, kidney tumors, nephrectomy, salt substitute